# ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)

> **NCT05890586** · PHASE3 · COMPLETED · sponsor: **Susanna Naggie, MD** · enrollment: 1331 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Fluvoxamine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05890586
- **Lead sponsor:** Susanna Naggie, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-08
- **Primary completion:** 2022-07-04
- **Final completion:** 2022-09-04
- **Target enrollment:** 1331 (ACTUAL)
- **Last updated:** 2023-09-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05890586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05890586, "ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05890586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*